Trial Demonstrates Potential of Blood Test to Reduce Late Detection of Lung Cancer
The Early Detection for Cancer of the Lung Scotland trial is believed to be the world’s largest trial for the detection of lung cancer using biomarkers.
Read MorePosted by Steve Halasey | Oct 15, 2019 | Immunoassay, Lung Cancer |
The Early Detection for Cancer of the Lung Scotland trial is believed to be the world’s largest trial for the detection of lung cancer using biomarkers.
Read MorePosted by Steve Halasey | Oct 11, 2019 | Allergy & Autoimmune, Infectious Diseases, Molecular Diagnostics, Research |
A new partnership promises a focus on patient applications.
Read MorePosted by Steve Halasey | Oct 8, 2019 | Breast |
The Ventana PD-L1 assay helps identify triple-negative breast cancer patients most likely to benefit from treatment with Tecentriq plus chemotherapy.
Read MorePosted by Steve Halasey | Oct 1, 2019 | Research |
RightEye’s technology quickly delivers precise eye-movement data by surveying the eye several times per second and recording its movements.
Read MorePosted by Steve Halasey | Sep 24, 2019 | Pancreatic |
Updated guidelines from the National Comprehensive Cancer Network recommend genetic testing for all patients with pancreatic cancer.
Read More